Essential Premium

D1 Capital Emerges as Largest Hedge Fund Holder of SpaceX

A slew of prominent hedge funds disclosed significant stakes in Elon Musk’s colossal company.

5th Annual Sub-Advisory Central Roundtable

November 3-4, 2026 | Park Hyatt Chicago

Why Over-relying on AI For Stock Picks is a ‘Recipe For Disaster’

When investors’ opinions become less diverse, “that's what causes manias and bubbles.”

Sponsored

The Evolving Private Equity Toolkit

Affinity, Janus Henderson Outpace Biopharma Peers in Tough Month

As most life sciences hedge funds lost money in July, Affinity Healthcare and Janus Henderson Biotech gained roughly 8 percent and 4 percent, respectively, extending their gains for 2026.

Related Content

D1 Capital Leads Tiger Crowd as Hedge Fund Returns Diverge in August

Stephen Taub

How One Firm Is Playing the Space Technology Venture Market

Alicia McElhaney

Is Venture Capital Finally Starting to Come Back?

Michelle Celarier

1270 Avenue of the Americas, Suite 1100

New York, NY 10020

 

© Institutional Investor, LLC. All material subject to strictly enforced copyright laws. Please read our Terms and Conditions and Privacy Policy before using the site. Institutional Investor is part of Delinian.

 

| Unsubscribe

LinkedIn
X (Twitter)
Bluesky
Instagram